Upcoming Program: June 13, 2017
Alix M. Lacoste
Data Scientist & SME, Watson Life Science Discovery
IBM is a global technology and innovation company headquartered in Armonk, NY. It is the largest technology and consulting employer in the world.
Avanlee Okragly, Vice President
SimpleC is a science based technology company that designs and delivers media-based behavioral therapies, presented as storyboards, to engage individuals.
Neel S. Madhukar, CEO
OneThree Biotech uses artificial intelligence to identify the mechanisms and downstream clinical effects of drugs in development.
Co-CEO of Singer Instruments and Control
Singer Instruments & Control specializes in the development, design and production of instruments and systems for industrial, medical and defense applications. The Company’s products are currently orbiting in space, sailing at sea (above and below water), implanted in the human body and assisting in complex medical procedures.
Founder, CEO and Partner at VivoSens Medical Read More…
*Dr. Kevin Olival – EcoHealth Alliance
The Global Virome Project: Predicting And Preventing The Next Pandemic
EcoHealth Alliance is a global environmental health nonprofit organization dedicated to protecting wildlife and public health from the emergence of disease. The organization develops ways to combat the effects of damaged ecosystems on human and wildlife health. Its team specializes in saving biodiversity in human-dominated ecosystems where ecological health is most at risk from habitat loss, species imbalance, pollution and other Read More…
Previous Program: February 28th, 2017
Schahram Akbarian, M.D., Ph.D.
Chief, Division of Epigenomics at Icahn School of Medicine at Mount Sinai
“The Human Brain And Its Epigenome”
Robert Rollins, Ph.D.
Pfizer Research & Development
Senior Principal Scientist, Oncology Therapeutics Discovery – Epigenetics
“Epigenetic Cancer Therapy: Promises and Challenges”
Krishnan Viswanadhan, Pharm.D., MBA
Celgene Corporation – Strategic Development Leader
“Development of IDH2 Inhibitor, Enasidenib in AML”